Company intelligence / Profile preview
VEB Deutsches Hydrierwerk Rodleben
- Ownership
- Private
- Development stage
- Commercial
Overview
VEB Deutsches Hydrierwerk Rodleben was a state-owned industrial chemical manufacturer in the former German Democratic Republic (East Germany), known for its expertise in catalytic hydrogenation processes. It is historically notable for synthesizing trapidil—a vasodilator and anti-platelet agent—in 1964[1], and for operating one of the largest continuous catalytic fixed-bed plants for glucose hydrogenation to produce sorbitol using copper/nickel catalysts[2]. The company did not operate as a pharmaceutical or biotech firm but supplied intermediates and bulk chemicals relevant to those industries.
- Industry
- Chemicals & Materials
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on VEB Deutsches Hydrierwerk Rodleben.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VEB Deutsches Hydrierwerk Rodleben.